Yuichi Takiguchi

10PUBLICATIONS
71CO-AUTHORS
Cancer geneticsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi

|Mar 16, 2024
Salivary gland-type cancers: cross-organ demographics of a rare cancer.

Aika Tanzawa, Kengo Saito, Masayuki Ota

|Jan 02, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).

Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi

|Sep 01, 2023
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.

Hirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi

|Apr 28, 2023
Efficacy and Safety of Electrohydraulic Lithotripsy Using Peroral Cholangioscopy under Endoscopic Retrograde Cholangiopancreatography Guidance in Older Adults: A Single-Center Retrospective Study.

Koji Takahashi, Hiroshi Ohyama, Yuichi Takiguchi

|Aug 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.

Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi

Pageof 2

Frequent Collaborators

4 joint publications

Hiroaki Okamoto

3 joint publications

Hirotsugu Kenmotsu

3 joint publications

Naoki Furuya

3 joint publications

Yoshimasa Shiraishi